Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 1Phase 2 Interventional

A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)

ClinicalTrials.gov ID: NCT01610765

Public ClinicalTrials.gov record NCT01610765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to identify if a Novel Antiviral Drug could be used to treat babies with Herpes Simplex Virus (HSV) with central nervous system (CNS) disease. In this study the investigators will identify the best dose for young children as well as identify additional safety information about the Novel Antiviral Drug.

Study identification

NCT ID
NCT01610765
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Day to 98 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2016 (Type not available)
Primary completion
Jun 2017 (Estimated)
Completion
Jun 2017 (Estimated)
Last update posted
Jun 7, 2016

2016 – 2017

United States locations

U.S. sites
18
U.S. states
17
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72202 —
University of Colorado at Denver Health Sciences Center Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of South Florida School of Medicine Tampa Florida 33606 —
Emory Children's Center Atlanta Georgia 30322 —
Louisiana State University Health Science Center -Shreveport Shreveport Louisiana 71103 —
Washington University in St Louis School of Medicine St Louis Missouri 63110 —
Dartmouth Medical School Lebanon New Hampshire 03756 —
Steven & Alexandra Cohen Children's Medical Center Of New York (CCMC) Manhasset New York 11030 —
University of Rochester Medical Center Rochester New York 14642 —
Carolinas Medical Center - Charlotte Charlotte North Carolina 28203 —
MetroHealth Medical Center Cleveland Ohio 44109 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Rhode Island Hospital Providence Rhode Island 02903 —
Vanderbilt University Medical Center Nashville Tennessee 37232-2581 —
University of Texas-Southwestern Dallas Texas 75390-9063 —
University of Utah School of Medicine Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01610765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01610765 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →